Bristol-Myers Squibb seeks further immuno-oncology patent revenues with AstraZeneca suit
The company has already secured lucrative settlements with Merck and Roche
The company has already secured lucrative settlements with Merck and Roche
Director General José Sánchez Pérez meets with local lawyers to discuss enforcement and implementation of IP law
Rigorous correlation analysis makes the case that IP rights are not the barrier to vaccine and treatment access that advocates claim, argues David Torstensson
16 February 2022
Agreements ending patent invalidity challenges risk falling foul of the country’s Anti-Monopoly Law
14 February 2022
The European Commission has launched the next step of the process towards further harmonisation of the patent extension rights.
11 February 2022
Petro Terblanche tells IAM about the IP issues surrounding her team’s new replica of Moderna’s covid-19 vaccine
10 February 2022
Versatile biotechnologies are changing patterns of collaboration among healthcare innovators
10 February 2022
EPO Board of Appeal seeks clarification on joint applicants approach to priority rights
04 February 2022
The billion-dollar-plus agreement shows the astronomical financial value that individual pharmaceutical patents can have
03 February 2022
Latest decision from London comes as plaintiff races against the clock to enforce soon-to-expire patent
01 February 2022
Tech sector brand assets gained significant value over the past year, according to the latest Brand Finance Global 500
31 January 2022
Spate of recent transactions show the value of gene-editing patents beyond Cas9
28 January 2022
Unlock unlimited access to all IAM content